KYMR’s Stock Market Adventure: 48.04% YTD Growth Amidst Volatility

OPEN Stock

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 48.04% this year. Over the last six months, there has been a weaker performance of 38.67%. The price of KYMR fallen by 14.66% during the last 30 days period. For the last 5-days stocks have improved 21.78%.

Kymera Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $45.31 on 02/27/24, while the lowest price during the same period was $9.60 on 11/02/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

52-week price history of KYMR Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Kymera Therapeutics Inc’s current trading price is -16.82% away from its 52-week high, while its distance from the 52-week low is 292.60%. The stock’s price range over this timeframe has been between $9.60 and $45.31. The shares of the Healthcare sector company recorded a trading volume of approximately 1.46 million for the day, which was comparatively higher than the average daily volume of 0.53 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Kymera Therapeutics Inc (KYMR) has experienced a quarterly rise of 3.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.31B and boasts a workforce of 187 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 36.41, with a change in price of +3.19. Similarly, Kymera Therapeutics Inc recorded 590,946 in trading volume during the last 100 days, posting a change of +9.11%.

KYMR’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for KYMR stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.

KYMR Stock Stochastic Average

Kymera Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 83.85%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 83.85%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 44.80% and 26.22%, respectively.

Most Popular